Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a product name.
BioCentury | Feb 17, 2014
Company News

Affinium, Debiopharm deal

BioCentury | Feb 12, 2014
Company News

Debiopharm acquires Affinium's antibiotic assets

BioCentury | Nov 18, 2013
Clinical News

AFN-1252 regulatory update

BioCentury | Sep 16, 2013
Clinical News

AFN-1720: Phase I started

BioCentury | Apr 1, 2013
Clinical News

AFN-1252: Phase IIa data

BioCentury | Aug 13, 2012
Clinical News

AFN-1252: Phase II started

BioCentury | Feb 6, 2012
Clinical News

AFN-1252: Phase II started

BioCentury | Aug 31, 2011
Financial News

Affinium adds $15M in B round

BioCentury | May 9, 2011
Clinical News

AFN-1252: Phase I data

BioCentury | Apr 26, 2010
Clinical News

AFN-1252: Phase I started

Items per page:
1 - 10 of 14